De novo variants in <i>SUPT16H</i> cause neurodevelopmental disorders associated with corpus callosum abnormalities.

Abstract

Whole-exome sequencing (WES) has identified de novo variants in chromatin remodelling genes in patients with neurodevelopmental disorders (NDD). We report on a novel genetic discovery in chromatin remodelling in patients with NDD who also have corpus callosum (CC) anomalies. To discover novel genes linked to both CC anomalies and NDD. Clinical WES was performed for evaluation of NDD, identifying five patients with de novo variants in <i>SUPT16H</i>, a subunit of the FACT (facilitates chromatin transcription) complex. The clinical phenotypes, genetic results and brain MRIs were obtained and systematically reviewed. In silico protein function predictions were assessed and allele frequencies in control populations were compared. We identified four patients with de novo missense variants in <i>SUPT16H</i> and one patient with a de novo deletion including <i>SUPT16H</i>. These variants were not reported in the updated Genome Aggregation Database. When assayable, all protein products were predicted to be damaging. Symptoms included intellectual disability, autistic features, minor dysmorphic features and seizures. Anomalies of the CC were seen in all three patients with available brain imaging. Our findings implicate the gene <i>SUPT16H</i> in a novel disorder characterised by neurodevelopmental deficits and CC anomalies.